EichorEICHOR
Condition: Childhood B Acute Lymphoblastic Leukemia Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Childhood B Acute Lymphoblastic Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NA · 7 location(s) · Miltenyi Biomedicine GmbH · NCT06508775Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Phase 3 · 24 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07152041Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Phase 1/Phase 2 · 11 location(s) · University Hospital Tuebingen · NCT05366218Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
NA · 3 location(s) · Rennes University Hospital · NCT06649253A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants
Phase N/A · 2 location(s) · Arkansas Children's Hospital Research Institute · NCT07422337CAR-T Cell Therapy for ALL
EARLY_Phase 1 · 1 location(s) · Dr. Zaineb Akram · NCT07695012Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06764238A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With Firs
Phase 2 · 68 location(s) · Pfizer · NCT05748171Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06882057Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Ly
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03136146Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Mali
Phase 1 · 2 location(s) · Sumithira Vasu · NCT05418088Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT04746209Ma-Spore ALL 2020 Study
Phase 2 · 3 location(s) · National University Hospital, Singapore · NCT06336395Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL
Phase 1 · 3 location(s) · Chulalongkorn University · NCT07078929
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.